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TGF-b superfamily signaling pathways emerged with the evolution of multicellular animals, suggesting that
these pathways contribute to the increased diversity and complexity required for the development and
homeostasis of these organisms. In this review we begin by exploring some key developmental and disease
processes requiring TGF-b ligands to underscore the fundamental importance of these pathways before
delving into the molecular mechanism of signal transduction, focusing on recent findings. Finally, we discuss
how these ligands act as morphogens, how their activity and signaling range is regulated, and how they
interact with other signaling pathways to achieve their specific and varied functional roles.Introduction
The transforming growth factor b (TGF-b) superfamily of growth
factors, which contains over 30 members including TGF-bs,
bone morphogenetic proteins (BMPs), growth and differentiation
factors (GDFs), Activins, and Nodal, is vital for the development
and homeostasis of metazoans (Feng and Derynck, 2005). The
ligands and their downstream pathway components are
extremely well conserved during evolution, and they regulate
diverse cellular functions such as growth, adhesion, migration,
apoptosis, and differentiation. Moreover, their actions are modu-
lated in time and space during embryonic development, leading
to a diversity of cellular responses that is staggering. The best
understood signal transduction pathway utilized by these growth
factors is seemingly simple and linear. Ligand dimers bind and
activate heteromeric complexes of type I and type II transmem-
brane receptors. Activated receptors then phosphorylate the
intracellular mediators (Smads), which form complexes with
each other and other proteins to modulate transcription of target
genes in the nucleus. However, in order to perform their varied
roles throughout animal life, there exists a level of complexity
we are only just beginning to understand. In this review we begin
by describing some key events in the development of both inver-
tebrates and vertebrates that require TGF-b superfamily
signaling, and some human diseases that result from deregu-
lated signaling. We then look at the pathway in greater molecular
detail, concentrating on recent published studies. Finally, we tie
together the functions of these ligands with the mechanisms by
which they signal to explain how the TGF-b superfamily signaling
pathways achieve their complex in vivo roles.
Functions of TGF-b Superfamily Members in Embryonic
Development and Disease
Early Development, Axis Formation, and Patterning
Members of the Nodal/Activin and BMP subfamilies are key
players in the generation of axes and in the subsequent
patterning of tissues across these axes during embryogenesis.
They are morphogens that form concentration gradients and
signal in a dose-dependent manner, thereby providing positional
information to a field of cells and initiating diverse downstream
molecular programs. Whereas the first asymmetry in the embryois often determined by localized maternal factors, sperm entry,
or both, zygotic activation of Nodal and BMPs initiates complex
circulatory loops of signaling to define and pattern the first
embryonic axis.
In Drosophila embryos, the BMP orthologs Decapentaplegic
(Dpp) and Screw (Scw) are required for dorsal-ventral (D/V)
axis specification and patterning. Prior to cellularization of the
blastoderm, dpp is expressed in the dorsalmost 40% of the
embryo, limited ventrally by a maternal NF-kB ortholog, Dorsal
(Dl) (Morisato and Anderson, 1995). After cellularization, a
gradient of Dpp signaling is established with highest activity
at the dorsal midline, lower activity at the lateral regions, and
no activity ventrally (O’Connor et al., 2006). Ubiquitously
expressed Scw synergizes with Dpp to attain the highest levels
of BMP signaling (O’Connor et al., 2006). Cells along this D/V
axis respond to different levels of Dpp signaling and undergo
different programs of differentiation. Highest levels of Dpp
specify the amnioserosa, lower levels specify dorsal ectoderm,
and lack of Dpp signaling allows the formation of neural ecto-
derm (O’Connor et al., 2006).
While vertebrate and arthropod embryos share a similar body
plan, their D/V axes are inverted. In arthropods, neural tissue
arises from ventral lateral ectoderm, while in vertebrates, it is
derived from dorsal ectoderm. Despite this difference, molecular
requirements for defining and patterning the D/V axis in verte-
brates and Drosophila are highly conserved (Little and Mullins,
2006). In Xenopus and zebrafish, an early zygotic manifestation
of the D/V axis is the dorsal organizer, which was originally iden-
tified in a salamander gastrula embryo and is sufficient to induce
ectopic dorsal tissue (Spemann and Mangold, 1924). It is known
as the Spemann organizer in Xenopus and the shield in zebrafish.
In both systems formation of the dorsal organizer requires Nodal
signaling (De Robertis and Kuroda, 2004; Feldman et al., 1998)
(Figure 1A). Studies have revealed that many of the factors
secreted from the organizer are BMP antagonists (De Robertis
and Kuroda, 2004). From the onset of zygotic transcription to
the end of gastrulation, Bmp4 and Bmp7 expression become
gradually limited to the ventral side of embryos in Xenopus,
with Bmp2b (swirl) and Bmp7 (snailhouse) undergoing similar
temporal and spatial regulation in zebrafish (Little and Mullins,Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 329
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(A) Overexpression (OE) of the Nodal ligand Xnr1 ventrally induces an ectopic organizer, resulting in a second axis, indicated by the white arrowheads.
(B) A ventral to dorsal gradient of BMP signaling patterns tissues in the early embryo. Bmp2b mutant fish are completely dorsalized, lacking ventrally derived
structures. Increasing expression of Xenopus BMP4 rescues the phenotype, and excess BMP signaling gradually ventralizes embryos.
(C) Inhibiting Nodal signaling in zebrafish with the type I ALK4/5/7-specific inhibitor SB-431542 results in gradual loss of mesodermal and endodermal tissue and
induces cyclopia and loss of anterior dorsal cell types. The arrow and the arrowhead indicate the eyes and notochord, respectively.
(D) Overexpression of Xnr1 in Xenopus embryos results in randomization of the L/R axis, which manifests as reversed heart and gut looping. v, ventricle.
(E) Overexpression of BMP antagonists Sog and Tsg in the Drosophila wing inhibits BMP signaling, resulting in lack of vein formation and a decrease in
proliferation.
(F) Loss of BMP2 and BMP4 in the mouse affects posterior digit development during limb morphogenesis as seen by Sox9 chondrogenic staining of digits.
The images were reproduced courtesy of Kishimoto et al. (1997) (B); Sun et al. (2006) (C); Sampath et al. (1997) (D); Shimmi and O’Connor (2003) (E); and
Bandyopadhyay et al. (2006) (F).2006). Higher BMP activity then induces other secreted factors
on the ventral side (De Robertis and Kuroda, 2004). In addition,
another BMP family member, Admp, is expressed in the Spe-
mann organizer, being inhibited by high BMP levels on the
ventral side (Reversade and De Robertis, 2005). The concerted
actions of these molecules set up a ventral to dorsal gradient
of BMP, capable of patterning tissues (Little and Mullins, 2006)
(Figure 1B). In the vertebrate ectoderm, high BMP activity
induces epidermis and low activity specifies neural tissue.
Neural crest cells are specified at the border between these
tissues in cells exhibiting intermediate BMP signaling (Sauka-
Spengler and Bronner-Fraser, 2008).
In contrast, the first zygotically induced axis in mice is the
anterior-posterior (A/P) axis, but again, Nodal is a key player.
Nodal is initially expressed throughout the epiblast, the radially
symmetrical cup-shaped embryo proper, and its involvement
can be summarized in three steps (Schier, 2003; Yamamoto
et al., 2004). First, Nodal is required for the induction of the distal330 Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc.visceral endoderm (DVE), part of the extraembryonic tissue.
Second, in response to Nodal, some cells of the visceral endo-
derm (VE) secrete Nodal antagonists, and inhibition of Nodal in
the vicinity of these cells prevents Nodal-induced proliferation
in a portion of the VE, hence providing asymmetry and positional
cues for determining anterior versus posterior. Third, Nodal
induces cells of the DVE to migrate toward the anterior
(becoming the anterior VE [AVE]), thus setting up the A/P axis.
Germ-Layer Specification, Patterning, and Gastrulation
In addition to its roles in axis specification, Nodal is also required
in vertebrates for the induction of the three germ layers: endo-
derm, mesoderm, and indirectly, ectoderm. It first induces mes-
endoderm, and then different levels of Nodal signaling are
required for further patterning and refinement of domains, with
high levels inducing endoderm and lower levels inducing meso-
derm (Zorn and Wells, 2007). In mice, Nodal antagonism by
secreted factors from the AVE, along with complex positive feed-
back circuits from the extraembryonic ectoderm (ExE), induces
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rior region of the epiblast during A/P axis formation, thus setting
up the Nodal gradient required for induction of endoderm and
mesoderm (Zorn and Wells, 2007). In Xenopus, the maternal
vegetally localized Nodal-related ligand Vg1 (Birsoy et al.,
2006), in conjunction with zygotically expressed Nodal ligands,
creates the required Nodal gradient in the vegetal pole, which
is high in the dorsal vegetal region and fades ventrally and
toward the animal pole (Schier, 2003). In zebrafish, a similar
enrichment of Nodal exists dorsally, proposed to result from
the accumulation of Squint (sqt) transcripts on the dorsal side
of the embryo at the four-cell stage (Gore et al., 2005). In fish,
a mutant lacking both the short and long-range ligands, Cyclops
(Cyc) and Sqt respectively, develops with no endoderm and
almost no mesoderm (Feldman et al., 1998), and a similar pheno-
type is seen in embryos treated with an inhibitor of Nodal recep-
tors (Sun et al., 2006) (Figure 1C).
The third germ layer, ectoderm, is often considered a default
tissue type, since tissues removed from the effects of Nodal
signaling become ectoderm (Zhang et al., 1998). However, in
the embryo, active inhibition of Nodal signaling is required
(Schier, 2003). Moreover, normal gastrulation cannot occur
without the appropriate specification of the three germ layers,
and loss-of-function mutations in Nodal signaling lead to severe
gastrulation and primitive streak defects (Zorn and Wells, 2007).
Left-Right Asymmetry
The left-right (L/R) axis is specified after the A/P and D/V axes
and is important for the future position of the organs and the
directional looping of tubules in the body. Here again, Nodal
plays a crucial role (Figure 1D). Nodal signaling during L/R spec-
ification is dynamic, both spatially and temporally. In mice,Nodal
is initially expressed symmetrically at E7.0 at the lateral edges of
the node. By E7.5, its expression shifts, with higher levels found
in the left perinodal region (Marques et al., 2004). Shortly after at
E8.0,Nodal expression is found in the left lateral plate mesoderm
(LPM). Genetic ablation of Nodal expression in the node has
demonstrated that Nodal is required for its own asymmetrical
expression later in the LPM, but how the signal is transduced
to manifest the later event is unclear (Brennan et al., 2002). In
Xenopus and zebrafish, where there are multiple Nodal ligands,
Xnr1 and Southpaw, respectively, are expressed asymmetrically
in the LPM (Long et al., 2003; Sampath et al., 1997).
BMP signaling is also involved in L/R patterning. Evidence
from mouse and chick reveal different roles. In mouse, BMP4
represses Nodal expression in the right LPM (Mine et al.,
2008). In the chick, BMP2 induces Nodal expression on the left
side (Schlange et al., 2002). Experiments in zebrafish suggest
that active BMP signaling can do both, but these are separate
events, regulated temporally. In this case, BMP4 is required at
early stages to suppress Nodal in the right LPM, but later, it is
required for left-side-specific gene expression (Chocron et al.,
2007).
Organogenesis and Developmental Disease
So far, we have discussed a few key players, mainly Nodal and
several BMPs, that are required for early embryogenesis. These
ligands continue to be deployed for later developmental
processes, along with other superfamily members that have
extensive and specialized roles in tissue morphogenesis and
homeostasis. A comprehensive and detailed listing of all TGF-bsuperfamily ligand functions is beyond the scope of this review,
so we will just highlight a few instructive examples.
InDrosophila, Dpp signaling is vital for the morphogenesis and
development of the imaginal discs, which give rise to the external
appendages and organs of the adult fly (O’Connor et al., 2006).
For example, in the early wing disc a Dpp gradient patterns the
A/P axis, providing accurate positional cues for longitudinal
vein (LV) formation (O’Connor et al., 2006) (Figure 1E). This initial
expression of dpp at the compartment boundary is also required
for proliferation of cells in the imaginal disc. Later during early
pupal development, dpp expression is refined to areas where
LVs have been specified. This maintains LV fate and contributes
to the induction of cross veins, which additionally requires
another Drosophila BMP ligand, Glass bottom boat (Gbb)
(O’Connor et al., 2006).
In vertebrates, one or more TGF-b superfamily ligands play
roles in the morphogenesis of most organs, and defects in
signaling in this context can lead to serious human diseases.
Anti-mu¨llerian hormone (AMH) is a highly specialized member
of the TGF-b family restricted in its expression both spatially
and temporally. This is in contrast to other family members previ-
ously discussed, such as BMP4 and Nodal, which are expressed
in many different tissues to elicit diverse responses. AMH is
required for the regression of mu¨llerian ducts in male fetuses
and deficiencies in AMH or the AMH receptor (AMHR) result in
Persistent Mu¨llerian Duct Syndrome (PMDS), where fetuses
that are genetically male develop with rudimentary female
organs. Usually, functional testes develop but do not descend,
and obstructions or other defects which occur during the forma-
tion of the secretory ducts can render individuals infertile (Josso
et al., 2006). AMH is also required for follicular development in
females. Its expression is used as a marker for follicular reserve
in adult women, and excessive AMH can cause polycystic ovary
syndrome (Wang et al., 2007).
TGF-b family members are well known for their ability to
induce epithelial-mesenchymal transition (EMT) (Yang and Wein-
berg, 2008). This process allows polarized cells of an epithelial
sheet to delaminate, assume a spindle-like mesenchymal shape,
migrate from their site of origin, and invade surrounding tissue
(Yang and Weinberg, 2008). EMT is essential for a variety of
developmental processes, a prominent example being the inva-
sion of the heart cushion by endocardial cells from the atrioven-
tricular (AV) canals, which eventually gives rise to heart valves
(Mercado-Pimentel and Runyan, 2007). In mice, TGF-b1, 2,
and 3 are expressed in the developing heart in temporally distinct
phases. While mice null for each of the three TGF-b ligands have
been generated, only the TGF-b2 null mouse exhibited EMT-
specific phenotypes in the heart. However, in chicken AV
explants, use of neutralizing antibodies has demonstrated that
TGF-b2 is required for initiation of EMT, while TGF-b3 affects
invasion/migration in a sequential manner, consistent with the
order of expression of these ligands. Since the expression of
the three TGF-bs is also temporally controlled in the mouse
heart, they may all contribute to EMT, but at different steps of
this process.
BMPs and GDFs make up the majority of the TGF-b superfamily
members, and BMP2, 4, and 7, as well as GDF5 and 6, have all
been implicated in limb development (Bandyopadhyay et al.,
2006; Settle et al., 2003) (Figure 1F). The BMPs are redeployedDevelopmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 331
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tion, AER regression, cartilage and bone differentiation, and inter-
digital webbing regression, and their temporal coexpression can
play synergistic as well as antagonistic roles depending on the
stage (Robert, 2007). In addition, TGF-b2 and 3 are also required
for inducing programmed cell death during interdigital webbing
regression (Dunker et al., 2002). Mutations in TGF-b superfamily
signaling components, such as the ligands GDF5 and CDMP1,
the type I BMP receptor BMPR1B, and the antagonist Noggin,
can lead to severe defects resulting in shortening of limbs and
loss of joints and/or digits as seen in diseases such as brachydac-
tyly (Lehmann et al., 2006, 2007; Seemann et al., 2005) and chon-
drodysplasia (Faiyaz-Ul-Haque et al., 2008; Thomas et al., 1997).
Homeostasis and Disease
TGF-b superfamily signaling continues to function in fully devel-
oped organisms where it is required for tissue homeostasis. A
well-studied example is the maintenance of the vasculature,
and relevant to this, mutations in a TGF-b receptor, Activin
receptor-like kinase 1 (ALK1), and a coreceptor, Endoglin, have
been linked to the disease Hereditary Hemorrhagic Telangiec-
tasia (HHT) or Rendu-Oslr-Weber syndrome (ten Dijke and
Arthur, 2007). Besides telangiectasis (formation of dilated blood
vessels at the surface of the skin and mucous membranes),
patients often have arteriovenous malformations, nosebleeds,
and gastrointestinal bleeding. Mutations in Endoglin are associ-
ated with HHT1 while mutations in ALK1 are linked to HHT2 with
the clinical diagnosis differing at the level of penetrance and
localization of malformations. In most cases, the mutations are
thought to inactivate receptor function and disease occurs due
to haploinsufficiency (ten Dijke and Arthur, 2007).
Interestingly, a subset of patients with HHT often also suffers
from juvenile polyposis (JP). JP is diagnosed when five or more
hamartomatous gastrointestinal polyps are found, usually in
the colon at a young age. Mutations in Smad4, a signal trans-
ducer downstream of TGF-b superfamily signaling, and a BMP
type I receptor,BMPR1A (ALK3), have been linked to the disease
(Levy and Hill, 2006). Interestingly, combined JP-HHT is linked to
mutations in Smad4 (Gallione et al., 2004). Intuitively, this makes
sense due to the role of Smad4 downstream of BMPR1A/ALK3,
ALK1, and Endoglin (see below). A study recently investigated
HHT patients that do not carry mutations in Endoglin or ALK1
and have not been diagnosed with combined JP and found
that 10% of these cases have mutations in Smad4 (Gallione
et al., 2006). Because JP is associated with a high risk of devel-
oping gastrointestinal cancers, HHT patients who have not been
diagnosed with JP may indeed be afflicted by the combined
syndrome and harbor this risk.
Another disease associated with the maintenance of the
vasculature is primary pulmonary arterial hypertension (PAH).
This results from remodeling of pulmonary arteries leading to
a constriction of the vessels that increases blood pressure and
decreases the efficiency of the heart in distributing oxygen-rich
blood to tissues around the body (ten Dijke and Arthur, 2007).
Prolonged stress to the heart due to PAH often leads to heart
failure and premature death. Germline mutations in the BMP
type II receptor, BMPR2, have been isolated in patients with
PAH. The changes in BMP signaling associated with these muta-
tions may contribute to an increased susceptibility of endothelial
cells to apoptosis, leading to damage of vessels. The same332 Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc.changes in signaling can also increase myofibroblast and
smooth muscle cell proliferation, leading to abnormal repair of
vessels (Eickelberg and Morty, 2007; Morrell, 2006).
Myofibroblasts are key players in wound-healing and tissue
repair. They respond to cues from TGF-b in order to carry out
this function. Therefore, disturbances in TGF-b signaling can
lead to fibrotic diseases, which are a result of excessive scarring
due to increased extracellular matrix (ECM) deposition by over-
active myofibroblasts. This abnormal scarring can eventually
interfere with organ function and lead to organ failure. Excessive
TGF-b signaling has been linked to fibrotic diseases and is
thought to function by promoting the production of ECM compo-
nents, in particular type I collagen (Gordon and Blobe, 2008), and
in renal fibrosis, by inducing EMT in renal epithelial cells, convert-
ing them to myofibroblasts, leading to tubular atrophy (Zeisberg
and Kalluri, 2004).
The importance of TGF-b’s involvement in the maintenance of
ECM is also evident in Marfan syndrome (MFS). This is a hereditary
congenital disorder resulting from connective tissue defects that
manifest in symptoms such as scoliosis (curved spine), arachno-
dactyly (long spidery fingers), dolichostenomelia (long slender
limbs), pectus excavatum (sunken chest), or carinatum (protrusion
ofchest), and sometimes ectopia lentis (mispositioningof the crys-
talline lens of the eyes) (Robinson et al., 2006). A large percentage
of patients diagnosed with MFS harbor mutations in the gene
Fibrillin-1. Initially, this finding attributed the disorder to problems
with the structural roles of Fibrillins in the ECM (Robinson et al.,
2006). However, Fibrillin-1 is a member of the Fibrillin/Latent
TGF-b binding protein superfamily and members of this family
play an important role in regulating TGF-b ligands. Indeed, MFS
type II is caused by mutations in TGFB2 and a related disease,
Loeys-Dietz syndrome (LDS), which has overlapping symptoms
with MFS, has been shown to be associated with mutations in
either TGFB1 or TGFB2 (Gordon and Blobe, 2008).
Due to the pleiotropic roles of TGF-b superfamily members, it
is not surprising that deregulation of TGF-b superfamily signals
can lead to the progression of many cancers. It was the
discovery in 1996 that TGF-b exhibited a biphasic action during
skin carcinogenesis, inhibiting the formation of benign tumors,
but enhancing the progression to invasive spindle tumors (Cui
et al., 1996), that crystalized the view that TGF-b plays both
tumor suppressive and tumor promoting roles in human cancer.
Since that time these roles have been dissected in detail, but as
this has been extensively reviewed recently (Massague, 2008), it
will not be discussed here.
The Molecular Mechanism of TGF-b Superfamily
Signaling
From the discussion above it is evident that TGF-b superfamily
members play critical and diverse roles throughout embryonic
development in vertebrates and invertebrates, and that deregu-
lated signaling contributes to many human diseases. These
ligands function by initiating new programs of gene expression
in responding cells and in this section we explain how this is
achieved. The best understood signaling pathway downstream
of the receptors is relatively simple, but a considerable amount
of combinatorial mixing and matching at the level of the ligands,
receptors, and Smads produces a large diversity in transcrip-
tional outputs.
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The TGF-b superfamily ligands are secreted as precursors
comprising a large prodomain and a C-terminal mature polypep-
tide. Dimerization, which is stabilizedby intermoleculardisulphide
bonds, requires the prodomains and thus occurs intracellularly.
The mature ligands are cleaved from the prodomain by furin-like
enzymes (Feng and Derynck, 2005). For the most part, the ligands
homodimerize, but heterodimerization also occurs between
Nodal and BMP4 or BMP7 (Yeo and Whitman, 2001) or, in
Drosophila, between Dpp and Scw (O’Connor et al., 2006). A
major regulatory step in TGF-b superfamily signaling is the regu-
lation of ligand accessibility by extracellular diffusible ligand-
binding proteins. This is particularly important for the creation of
gradients, such as the D/V BMP gradient as discussed in more
detail below. Examples of such ligand-sequestering molecules
are the BMP antagonists Chordin/Short gastrulation (Sog),
Noggin, Twisted gastrulation (Tsg), Crossveinless-2 (Cv-2), Scle-
rostin, members of the DAN family, and Follistatin, an Activin
inhibitor that also interacts with BMPs and GDF8 (De Robertis
and Kuroda, 2004).
The Receptors
TGF-b superfamily members require two different serine/threo-
nine kinase receptors to signal, a type I and a type II. There are
seven type I receptors (ALKs 1–7) and five type II receptors in
the human genome (for phylogenetic trees, see Schmierer and
Hill, 2007). The ligand brings the receptors together in a heterote-
trameric complex in which the type II receptors phosphorylate
and activate the type I receptors (Figure 2A). For some ligand-
receptor interactions, coreceptors, such as Betaglycan, Endo-
glin, and members of the EGF-CFC family, are also required
(Feng and Derynck, 2005). In the case of the TGF-b receptors,
the ligand-receptor interaction is highly cooperative. The
ligand-receptor complexes assemble through the recruitment
of the low-affinity type I receptor by the ligand-bound high-
affinity type II receptor, facilitated by direct type I-type II interac-
tions at the composite ligand-type II interface (Groppe et al.,
2008). In contrast, the BMP receptor complexes do not
assemble cooperatively and the type I and type II extracellular
domains do not interact directly. Instead they are linked via the
ligand, and membrane localization may also promote ligand-
receptor assembly (Groppe et al., 2008).
It is becoming apparent that many different combinations of
ligand-receptor interactions and type I and type II receptor pair-
ings can occur, creating a huge potential diversity in the outputs
of the signaling pathways (Feng and Derynck, 2005). If the ligands
have different affinities for distinct receptor combinations, then it
is easy to see how ligand dose-dependent responses may be
generated. For the most part, the type II and type I receptor dimers
in a ligand-receptor complex are assumed to be homodimers.
However, in endothelial cells TGF-b activates both ALK1 and
ALK5, and a complex has been proposed comprising these two
distinct type I receptorsalongwith theTGF-b type II receptorTbRII
(Goumans et al., 2003). Similarly, mixed receptor complexes
containing TbRII, ALK5, and either ALK2 or ALK3 have been
proposed to mediate a novel branch of TGF-b signaling in epithe-
lial cells (Daly et al., 2008). In this case, higher concentrations of
TGF-b are required to activate the putative heteromeric TbRII-
ALK5-ALK2/3 receptor complex, compared with the canonical
TbRII-ALK5 receptor complex. InDrosophila, a receptor complexcomprising the two type I receptors Thickveins (Tkv) and Saxo-
phone (Sax) and the type II receptor Punt appears to be costimu-
lated by a ligand heterodimer comprising Dpp and Scw to elicit
highest levels of signaling (O’Connor et al., 2006).
The TGF-b receptors are internalized constitutively in a cla-
thrin-dependent manner into EEA1-positive early endosomes
and in a non-clathrin-dependent manner via caveolin-positive
lipid rafts (Di Guglielmo et al., 2003) (Figure 2B). Receptor
signaling and degradation are thought to occur in different
cellular compartments. Receptor degradation occurs via the
lipid raft-caveolar internalization pathway. It is mediated via
Smad7, which is a member of the Smad family (see below),
which recruits the HECT domain E3 ubiquitin ligases Smurf1/2
to the activated type I receptors to degrade them (Feng and Der-
ynck, 2005). Receptor dephosphorylation also occurs, mediated
via the phosphatase PP1, which is targeted to the active type I
receptors with its regulatory subunit GADD34, again by Smad7
(Shi et al., 2004). It is not clear in which cellular compartment
this occurs, although it is tempting to speculate that it might be
part of the receptor recycling pathway (Figure 2B). Active
signaling is thought to occur in the endosomes (Di Guglielmo
et al., 2003). Work on the Nodal/Activin pathway in Xenopus indi-
cates that receptor trafficking is controlled by the Ras GTPase
family member Rap2 (Choi et al., 2008). In the absence of signal,
Rap2 directs the receptors into a recycling pathway via early
sorting endosomes, which prevents their degradation and main-
tains their levels at the plasma membrane. Upon Nodal/Activin
stimulation, Rap2 delays receptor turnover to promote receptor
activity (Choi et al., 2008) (Figure 2B).
The Smads
The most studied signaling pathway downstream of TGF-b
superfamily receptors is the Smad pathway. The Smads are
a group of intracellular signaling molecules comprising the
receptor-regulated Smads (R-Smads) Smad1, 2, 3, 5, and 8,
the co-Smad Smad4, and the inhibitory Smads Smad6 and 7.
Upon ligand stimulation, the R-Smads are phosphorylated by
the type I receptors at two serines in an S-M/V-S motif at their
extreme C termini (Massague et al., 2005). They then form both
homomeric and heteromeric complexes with Smad4 that accu-
mulate in the nucleus and directly regulate the transcription of
target genes (Figure 2A). The original view of TGF-b superfamily
signaling pathways were that there were two branches: a BMP/
GDF branch signaling through ALKs 2, 3, and 6 and R-Smads
1, 5, and 8; and a TGF-b/Nodal/Activin branch signaling through
ALKs 4, 5, and 7 and R-Smads 2 and 3 (Massague et al., 2005).
However, this is an oversimplification, since some GDFs, for
example GDF8, 9, and 11, signal through ALKs 4, 5, and 7 (Schmi-
erer and Hill, 2007). Moreover, TGF-b activates both Smad2/3
and Smad1/5/8 in a variety of endothelial, epithelial, fibroblast,
and tumor cells (Bharathy et al., 2008; Daly et al., 2008; Goumans
et al., 2003; Liu et al., 2009). In epithelial cells this results in the
formation of mixed R-Smad complexes, containing, for example,
activated Smad1 and Smad2 in addition to the canonical Smad2/
3-Smad4 complexes (Daly et al., 2008) (Figure 2A).
The mechanism whereby ligand stimulation leads to nuclear
accumulation of active Smad complexes is now well understood.
The R-Smads and Smad4 constantly shuttle between the cyto-
plasm and nucleus, both in unstimulated and ligand-stimulated
cells, and nuclear accumulation of active Smad complexes isDevelopmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 333
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and an increase in import rate compared with monomeric Smads
(Schmierer et al., 2008). The failure of Smad complexes to be
exported may result from their active retention in the nucleus.
Consistent with this the transcriptional regulator TAZ has been
demonstrated to bind nuclear Smad2/3-Smad4 complexes
and is recruited with them to TGF-b-responsive promoter
elements (Varelas et al., 2008). If TAZ is knocked down, Smad2
and 3 do not accumulate in the nucleus upon TGF-b stimulation.
A prerequisite for Smad nuclear export during signaling is Smad
dephosphorylation, and several Smad phosphatases have been
identified. Smad1 phosphatases include pyruvate dehydroge-
nase phosphatase (PDP) and small C-terminal phosphatases
(SCP1, 2 and 3), while PPM1A can dephosphorylate both subsets
of R-Smad (Chen et al., 2006; Knockaert et al., 2006; Lin et al.,
2006). In none of these cases does knockdown of the phospha-
tase completely abolish Smad dephosphorylation when the
receptors are inactivated, leaving open the possibility that other
Smad C-terminal phosphatases remain to be discovered.
Activated Smad complexes bind to promoter sequences and
regulate transcription both positively and negatively (Figure 2C).
This has recently been extensively reviewed (Ross and Hill,
2008), so we will just summarize the salient points here. Different
activated Smad complexes have distinct DNA sequence speci-
ficities, explaining the diverse transcriptional responses of
different TGF-b superfamily members. The N-terminal MH1
domains of Smad3 and 4 recognize the sequence 50-GTCT-30
or its reverse complement, 50-AGAC-30, and complexes of
Smad3 and Smad4 thus bind direct or inverted repeats of these
Smad binding elements (SBEs) (Dennler et al., 1998). Smad1/5
bind the GC-rich consensus 50-GRCGNC-30 and when com-
plexed with Smad4, bind a combinatorial site comprising the
GC-rich element and an SBE spaced five base pairs apart (Pyro-
wolakis et al., 2004). These complexes are stabilized by the tran-
scriptional regulator Schnurri, which contacts both Smads.
These Smad1/5-Smad4-Schnurri complexes are inhibitory in
Drosophila, but activatory in mammalian tissue culture cells
(Yao et al., 2006). In fact inDrosophila, many Dpp-induced target
genes are not directly regulated by an activatory Smad1-Smad4
complex as they are for vertebrate BMP target genes, but are indi-
rectly induced through repression of a transcriptional repressor
Brinker (Brk). brk is repressed by Dpp signaling via a Schnurri-
Smad1-Smad4 complex, and loss of Brk then derepresses the
Dpp target genes (Pyrowolakis et al., 2004). In the case of
Smad2, although a spliced variant exists that binds DNA indistin-
guishably from Smad3, the major Smad2 isoform does not bind
DNA directly and thus most Smad2-Smad4 complexes are
recruited to DNA through interactions with other transcriptionfactors (for reviews see Feng and Derynck, 2005; Ross and Hill,
2008). Well-characterized examples of Smad2-interacting tran-
scription factors are the FoxH1 family of winged-helix transcrip-
tion factors and members of the Mix family of homeobox proteins,
Mixer, Milk, and Bix3, which recruit Smad2-Smad4 complexes to
target gene promoters in response to Nodal signaling (Kunwar
et al., 2003; ten Dijke and Hill, 2004). Importantly, these two fami-
lies of transcription factors exhibit different expression patterns
and have different DNA-binding specificities (Hill, 2001), and
thus they dictate cell-type-specific responses, mediating tran-
scription of different sets of genes in distinct cell types in
response to Nodal signaling (Hoodless et al., 2001; Kunwar
et al., 2003; ten Dijke and Hill, 2004).
All Smad-DNA binding interactions have been studied to date
in the context of R-Smad-Smad4 complexes, but a considerable
number of TGF-b-induced genes do not require Smad4 for their
regulation (Levy and Hill, 2005). It is possible that complexes con-
taining only R-Smads, which form in the absence of Smad4, may
be recruited to promoters of such genes. Indeed, Smad2/3 has
been shown to interact with the nuclear IkB kinase a (IKKa) in
the absence of Smad4 to regulate transcription of the Myc antag-
onistMad1 (Descargues et al., 2008). Furthermore, the transcrip-
tional regulator TRIM33/Tif1g/Ectodermin has been suggested to
act as an alternative Smad4 to promote TGF-b-induced erythroid
differentiation (He et al., 2006), although this is controversial as
TRIM33/Tif1g/Ectodermin, which is a RING-finger-containing
E3 ubiquitin ligase, was previously identified as a negative regu-
lator of Smad4 (Dupont et al., 2005). The very recent discovery
that activated R-Smad complexes act in the absence of Smad4
to regulate the processing of a microRNA, miR-21, raises the
very interesting possibility that the Smads can additionally
regulate gene expression without directly affecting transcription
(Davis et al., 2008).
The Smads absolutely require chromatin to assemble the
basal transcription machinery and activate transcription, and
so predominantly act through chromatin remodeling. This is in
contrast to most transcription factors, which can directly recruit
the basal machinery to proximal promoters (Ross et al., 2006)
(Figure 2C). Smad-induced chromatin remodeling requires the
histone acetylase p300, which specifically acetylates histone
H3 on lysines 9 and 18, and also the SWI/SNF component
Brg1 (Ross et al., 2006; Xi et al., 2008). Undoubtedly other chro-
matin remodeling and histone modifying enzymes are also
involved.
Non-Smad Signaling
Although the Smads are the best understood signal transducers
downstream of TGF-b superfamily receptors, other signaling
pathways can also be activated directly in response to TGF-b.Figure 2. Summary of the Molecular Mechanism of TGF-b Superfamily Signaling
(A) Heterotetrameric receptor complexes are activated by ligand dimers (red and green triangles) and phosphorylate downstream effectors, the R-Smads
(Smad1/5/8/2/3). Phosphorylated R-Smads then form complexes with each other (right-hand side of figure) and/or the co-Smad, Smad4 (left-hand side of figure),
and accumulate in the nucleus to regulate target gene transcription. The function of the mixed R-Smad complexes in the nucleus is not yet clear (Daly et al., 2008).
Transcription factors (TF) cooperate with Smad complexes on DNA. Nonphosphorylated monomeric Smads shuttle in and out of the nucleus. Multimeric
complexes dissociate after R-Smad dephosphorylation in the nucleus and shuttle back to the cytoplasm. This is a receptor activity monitoring system.
(B) Receptors are internalized constitutively via clathrin-mediated endocytosis and caveolin-positive lipid rafts. Smad7/Smurf2-mediated degradation occurs in
lipid rafts while receptors are recycled to the plasma membrane through endosomes. Active signaling occurs in EEA1-positive early ensodomes where SARA
presents R-Smads to activated receptor complexes. PP1 dephosphorylates receptors in a Smad7-dependent manner. The Ras GTPase Rap2 promotes recy-
cling in the absence of signal and delays recycling in presence of signal.
(C) Smad-dependent transcription requires chromatin remodeling. Smads recruit the histone deacetylase p300 and Brg1-SWI/SNF complex. Nucleosome
remodeling and histone modification, for example histone H3 acetylation (AcH3), then allows the recruitment of the basal transcriptional machinery.Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 335
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lial polarity, leading to the dissolution of tight junctions, an initi-
ating step in EMT (Ozdamar et al., 2005). TGF-b can also activate
the ERK MAP kinase (MAPK) signaling pathway through the
ability of ALK5 to phosphorylate the scaffold protein ShcA, which
recruits Grb and Sos, thereby activating Ras and downstream
MAPKs (Lee et al., 2007). Moreover, two very recent papers
have described the mechanism whereby TGF-b induces JNK
and p38 MAPK signaling (Sorrentino et al., 2008; Yamashita
et al., 2008). In this case, TRAF6 interacts with the TGF-b recep-
tors and TGF-b induction leads to K63-linked ubiquitination of
TRAF6. This in turn leads to activation of the MAPKKK Tak1,
an upstream activator of JNK and p38. Finally, in mesenchymal
cells, but not epithelial cells, TGF-b activates the kinase PAK2
and this occurs via the activation of the small GTPases Rac1
and Cdc42 (Wilkes et al., 2003). The basis of this cell type spec-
ificity is now explained in a paper in this issue (Wilkes et al.,
2009). The authors show that in fact in both cell types TGF-b
can activate PAK2, but in epithelial cells activated PAK2 is
bound and inhibited by a complex of Erbin and the tumor
suppressor Merlin. This does not occur in mesenchymal cells
as they express very low levels of Erbin.
How Do TGF-b Superfamily Members Achieve
Their In Vivo Roles?
To achieve the in vivo roles in embryonic development summa-
rized in the first section, TGF-b superfamily ligands must be
capable of functioning in a graded fashion as morphogens (for
example BMPs during D/V patterning in Drosophila and verte-
brates) and/or be able to signal in a highly dynamic manner
both spatially and temporally (for example Nodal in L/R
patterning and BMPs/GDFs during vertebrate limb develop-
ment). Having outlined the intracellular signaling pathways in
the second section, we now highlight the known mechanisms
that regulate the formation of ligand gradients and dynamic
signals, and those that regulate the downstream pathway to
interpret the signals and determine the specificity of the
responses. We discuss how BMPs are able to form gradients
of ligand activity, which, over time, frequently sharpen to step-
wise signals that ultimately define different tissue types (Suther-
land et al., 2003) (Figure 3). We examine how graded signals are
sensed by receiving cells, leading to differential transcriptional
responses according to ligand dose. In both of these areas,
mathematical modeling has proved to be a very powerful tool
and this will be highlighted. We also discuss how the range of
signaling is determined, newly discovered mechanisms whereby
signal strength, duration, or both are modulated, and how other
signal transduction pathways modulate TGF-b superfamily
signaling. All of these regulatory mechanisms provide qualitative
and quantitative differences in signaling that are capable of
increasing the diversity of functional outputs.
Generating Gradients of TGF-b Superfamily Ligand
Activity
Our current understanding of gradient formation derives mostly
from studies in Drosophila, and these studies will thus be a focal
point for our discussion. The traditional view of morphogen
gradients is that the ligand is secreted from a localized source,
diffuses across a field of cells, and forms a concentration
gradient in the target tissue (reviewed in Kicheva and Gonza-336 Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc.lez-Gaitan, 2008). The Dpp gradient that specifies A/P patterning
of the Drosophila wing obeys this paradigm. During larval devel-
opment, Dpp is secreted in the wing imaginal disc from a central
stripe of cells and forms a concentration gradient both anteriorly
and posteriorly. This gradient has an approximately exponential
shape, governed by the rates of ligand diffusion, production, and
degradation, and the presence of an immobile fraction (Kicheva
and Gonzalez-Gaitan, 2008). The exact mechanism whereby the
ligand spreads is still a matter of debate. One proposed mecha-
nism involves transcytosis (Kicheva et al., 2007), where Dpp is
secreted from the producing cells and then endocytosed and
secreted by neighboring cells. An alternative mechanism is that
Dpp simply diffuses through the target tissue, with its diffusion
rate being restricted by heparan sulfate proteoglycans (Kicheva
and Gonzalez-Gaitan, 2008). In reality both mechanisms may be
relevant (Affolter and Basler, 2007). Interestingly, the staining
pattern of phosphorylated Mad (P-Mad), the downstream signal
transducer, in the wing disc does not correlate with Dpp ligand
concentration, suggesting that additional BMP ligands are
involved. Indeed Gbb, which is broadly expressed in the wing,
also signals in the wing disc, acting over long distances, while
Dpp acts over a shorter range (Bangi and Wharton, 2006).
In contrast to the wing disc, a gradient of Dpp activity forms in
the early Drosophila embryo within a domain of uniform Dpp
mRNA expression in the dorsalmost 40% of the embryo. This
means that gradient formation cannot simply involve diffusion
Figure 3. BMP Signaling Gradients in Early Embryos
(A) mRNA and protein distributions in the Drosophila blastoderm and early
gastrula.
(B and C) BMP signal activity as detected by phospho-R-Smads in Drosophila
(P-Mad) (B) and zebrafish (P-Smad5) (C). In both cases, BMP signaling activity
is weak and diffuse over a broad area to begin with, but becomes increasingly
localized, at the dorsal midline forDrosophila, and on the ventral side for zebra-
fish, with a gradient of activity diminishing toward the lateral regions.
These images are taken from Rushlow et al. (2001) (B) and Tucker et al. (2008)
(C) with permission.
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tribution of ligand within the expression domain (Figure 3A). An
important feature of the underlying mechanism is that Dpp acts
together with another ligand, Scw, expressed uniformly in the
blastoderm. Homomeric and heteromeric dimers of Dpp and
Scw form and bind with different affinities to the ligand antago-
nists Sog and Tsg (O’Connor et al., 2006). sog is expressed in
ventral lateral regions, while tsg is expressed in the dorsal half
of the embryo (O’Connor et al., 2006) (Figure 3A). Dpp-Scw het-
erodimers bind with high affinity to Sog and Tsg, forming
a complex incapable of binding receptors, and are transported
away from the source of Sog to the dorsal midline. There, they
are released from Sog and Tsg as a result of Sog cleavage by
a dorsally expressed metalloprotease, Tolloid (Tld), allowing the
ligand dimer to activate receptor complexes containing the
type I receptors Tkv and Sax (O’Connor et al., 2006). Tld-induced
cleavage of Sog in more lateral regions results in rebinding of
Dpp-Scw to other molecules of Sog and Tsg, due in part to higher
levels of Sog in these regions. Homodimers of Dpp and Scw have
lower affinity for Sog and Tsg and thus are not transported as far
and are thought to elicit the weaker BMP signal in dorsal lateral
regions of the embryo. Mathematical modeling suggests that
this mechanism can account for a BMP ligand concentration
gradient. However, it predicts that over time the domain of
P-Mad would broaden and P-Mad levels would increase in inten-
sity, whereas in reality, the dorsalmost region of high P-Mad
activity actually contracts, giving a step gradient (O’Connor
et al., 2006) (Figure 3B). The most likely explanation is that there
is positive feedback in the system such that the initial Dpp-Scw
signal induces an as yet unidentified component that either
reduces the interaction of receptors with an inhibitory factor or
promotes ligand binding to receptors (Wang and Ferguson,
2005). Very recently, type IV collagens have been shown to play
a role in formation of the Dpp D/V gradient, promoting assembly
of the Dpp/Scw-Sog-Tsg complex, and in the absence of Sog,
facilitating Dpp/Scw-receptor interactions, thus amplifying the
signal at the dorsal midline (Wang et al., 2008).
This mechanism for gradient formation might not be unique to
the early Drosophila embryo, but may also function in early Xen-
opus embryos, where the BMP ligands are also expressed in
a very broad domain, but nevertheless develop into a ventral-
dorsal activity gradient (Little and Mullins, 2006). Xenopus ortho-
logs of sog (known as Chordin in vertebrates), tsg, and tolloid
have all been identified and biochemically the proteins have
been shown to act in the same way as in Drosophila (Oelgeschl-
ager et al., 2000; Piccolo et al., 1996, 1997; Sasai et al., 1995).
Mathematical modeling has been used to compare two possible
mechanisms of BMP gradient formation in Xenopus embryos
(Ben-Zvi et al., 2008). One model assumes an inhibition-based
mechanism whereby a gradient of BMP antagonists is created
over a uniform field of BMP ligands, and the other assumes
a shuttling-based mechanism where the ligands are transported
by inhibitors as described above for Dpp-Scw. The authors
found that while both mechanisms can generate a BMP activity
gradient, the shuttling-based mechanism gives a sharper and
more robust gradient. These models were tested experimentally
and the evidence suggested that the shuttling-based mecha-
nism could be involved in BMP gradient formation in Xenopus
embryos.Very recently another molecule involved in D/V axis formation
in Xenopus embryos has been identified. ONT1, a member of the
Olfactomedin family of secreted proteins, has been shown to
maintain appropriate Chordin levels in dorsal regions by acting
as a scaffold between Chordin and BMP1/Tld-class proteases,
promoting Chordin cleavage and degradation (Inomata et al.,
2008). This is required to prevent uncontrolled increases in Chor-
din levels that could shift the BMP gradient and lead to expan-
sion of the dorsal domain.
How Gradients Are Sensed and Interpreted
Ligand gradients must be quantitatively sensed and interpreted,
and several features of the TGF-b superfamily signaling pathway
have been uncovered that help explain how this is accomplished.
The Smad pathway is ideal for interpreting graded signals, as it
has no amplification steps (Schmierer and Hill, 2007). Moreover,
continuous shuttling of the Smads between the cytoplasm and
nucleus during signaling, mediated by cycles of receptor-induced
Smad phosphorylation in the cytoplasm and constitutive Smad
dephosphorylation in the nucleus, allows the Smads to constantly
monitor receptor activity (Schmierer and Hill, 2007). This concept
has been explored by mathematical modeling, which has
confirmed that the levels of active Smad2-Smad4 complexes in
the nucleus directly reflect the activation level of the receptors
at all times during signaling (Schmierer et al., 2008) (Figure 4). In
this way both the strength and duration of signaling is constantly
monitored. The computational model was used to identify indi-
vidual steps in the signaling cascade that, when modulated, can
affect system output most significantly. The most important
step for positively influencing the peak concentration of nuclear
active Smad2-Smad4 complexes is Smad2 phosphorylation,
while Smad2 dephosphorylation, dissociation of active Smad
complexes, and Smad4 nuclear export are the steps that have
the most negative influence (Schmierer et al., 2008). Consistent
with this, studies inDrosophilahave shown that the nuclear export
rate of the Drosophila Smad4 Medea is promoted by SUMOyla-
tion and, as a consequence, failure to SUMOylate Medea results
in increased Dpp signaling range (Miles et al., 2008).
Just as the levels of receptor activity are continuously moni-
tored, so the ligand levels must be sensed accurately and
dynamically by the receptors. This is currently not well under-
stood. It is tempting to speculate that constitutive receptor recy-
cling through the endocytic pathway (Di Guglielmo et al., 2003;
Figure 2B) may act to monitor ligand levels in an analogous
fashion to the Smads’ monitoring of receptor activity. A similar
mechanism is known to be important for controlling the duration
of EGF signaling (Sigismund et al., 2008).
Smad nucleocytoplasmic shuttling results in levels of acti-
vated nuclear Smad complexes that reflect the extent of
receptor activation, but how is signal intensity ‘‘translated’’ into
differential gene expression programs? An important determi-
nant is the affinity of Smad-binding sites for activated Smad
complexes, and this has been directly demonstrated in the early
Drosophila embryo for the Dpp target gene race. Increasing the
affinity of the Smad-binding sites in its enhancer placed
upstream of a reporter gene broadened the reporter expression
pattern (Wharton et al., 2004). However, as discussed above,
many Dpp target genes in the Drosophila embryo are not acti-
vated by Dpp per se, but are derepressed as a result of Dpp-
induced repression of the transcriptional repressor Brk. MultipleDevelopmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 337
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Schnurri-Mad-Medea complexes, resulting in an inverse expres-
sion gradient relative to the Dpp activity gradient (Yao et al.,
2008). Some Dpp concentration-dependent transcription is
then explained by the fact that Dpp-responsive genes have Brk
binding sites with different affinity in their enhancers. In addition,
although loss of Brk-induced repression is sufficient for activa-
tion of some genes, others additionally require binding of activa-
tory Mad-Medea complexes (Affolter and Basler, 2007). For
Smad2-dependent responses in vertebrates, the affinity of acti-
vated Smad2 for the DNA-bound Smad2-interacting transcrip-
tion factors may play a role in interpreting the level of signal
intensity (Randall et al., 2004).
We have discussed mechanisms that allow cells to interpret
a signaling gradient. However, cells also need to be competent
to respond to the signals. In early zebrafish embryos, this seems
to be regulated in a temporal fashion (Tucker et al., 2008). The
developing embryo may be thought of as a four-dimensional
system, since besides acting in space, gradients may achieve
functional diversity by acting over time as well. Using heat shock
induction of Chordin to inhibit BMP signaling at different times
during zebrafish development, Tucker et al. (2008) tested how
time is involved in the response of tissues to the BMP gradient.
Figure 4. Nucleocytoplasmic Shuttling of the SmadsActs as a Signal
Interpretation System
(A) Using the mathematical model of nucleocytoplasmic shuttling, receptor
levels were altered in a step-wise fashion as shown. The simulation demon-
strates that Smad nucleocytoplasmic shuttling couples the amount of nuclear
Smad2-Smad4 complexes to receptor activity, although with a time delay.
(B) Because of this delay, fluctuations in receptor activity are strongly damp-
ened and do not cause corresponding fluctuations in the concentration of
nuclear Smad2-Smad4 complexes.
This image was taken from Schmierer et al. (2008) with permission.338 Developmental Cell 16, March 17, 2009 ª2009 Elsevier Inc.Interestingly, cells along the A/P axis become competent to
respond to BMP signals in a temporal fashion such that as
gastrulation proceeds, progressively more caudal cells respond
to the BMP gradient and adopt their D/V identity. This temporal
regulation thus coordinates D/V with A/P patterning.
Determinants of Signaling Range
Several studies have revealed that distinct TGF-b family
members have very different signaling ranges in vivo (Chen and
Schier, 2001; Jones et al., 1996), and this seems to be determined
by the ligand prodomain, which is the least conserved part of the
protein. Prodomain swapping and mutation experiments have
demonstrated that these domains can affect the stability of these
proteins (Cui et al., 2001; Le Good et al., 2005). In most cases,
stability is affected during secretion of the ligands, and limiting
the concentration of the secreted product limits their range.
Indeed, the prodomain of the short-range zebrafish Nodal ligand
Cyc contains a lysosome-targeting region that destabilizes the
precursor and thus restricts Cyc activity (Tian et al., 2008). Addi-
tionally, BMP4 precursors are cleaved sequentially at two sites in
the prodomain. The first cleavage site activates the ligand, while
the second cleavage site affects stability and range (Cui et al.,
2001; Sopory et al., 2006). Posttranslational modifications of
domains, such as glycosylation, in addition to cleavage, also
contribute to ligand regulation (Le Good et al., 2005).
Signal range can also be influenced by the interaction of
ligands with secreted binding partners, and a good example of
this is Cv-2. Unlike Chordin, Cv-2 is not diffusible, but is tethered
to the membrane by heparan sulfate proteoglycans and thus
modulates BMP signals over a short range (Serpe et al., 2008).
Studies focusing on the role of Cv-2 in the Drosophila wing indi-
cate that Cv-2 activates BMP signaling at low concentrations,
but antagonizes it at higher concentrations (Serpe et al., 2008).
Moreover, Cv-2 binds BMP type I receptors as well as ligands.
As with other aspects of TGF-b superfamily signaling, mathe-
matical modeling has been used to gain insights into the mech-
anism (Serpe et al., 2008). The model suggests that a transient
low-affinity tripartite complex forms and facilitates ligand-
receptor binding, but at high Cv-2 concentrations, this is
compromised and it instead sequesters ligands to inhibit
signaling. A crystal structure of the Cv-2 N-terminal Von Wille-
brand factor type C domain 1 (VWC1) bound to BMP2 reveals
that Cv-2 sequesters ligand by blocking receptor binding sites
(Zhang et al., 2008). Since Cv-2 is itself induced by BMP activity,
Cv-2 expression not only serves as a direct measure of BMP
activity, but functions as part of a very effective feedback loop
capable of maintaining signaling activity at an appropriate level
and preventing runaway signaling.
As in Drosophila, Cv-2 is expressed in regions of high BMP
signaling in both Xenopus and zebrafish embryos (Ambrosio
et al., 2008; Rentzsch et al., 2006). The zebrafish Cv-2 also has
pro- and anti-BMP effects, and loss-of-function experiments
reveal that Cv-2 has mainly a signal-promoting function, since
Cv-2 morphants are moderately dorsalized (Rentzsch et al.,
2006). However, in Xenopus, Cv-2 has a predominantly inhibitory
role in BMP signaling, and may be part of a complex molecular
circuit through its interactions with other secreted modulators
of BMP signaling (Ambrosio et al., 2008). Cv-2 is capable of syn-
ergizing with the BMP-induced modulator Tsg to act as a local
feedback inhibitor on the ventral side of the embryo. It also
Developmental Cell
Reviewinteracts with Chordin, and may exert a pro-BMP signaling influ-
ence by concentrating diffusable Chordin-BMP-Tsg in ventral
regions of the embryo (Ambrosio et al., 2008).
Modulation of TGF-b Superfamily Signaling Activity
and Dynamics
Spatial and temporal control of Nodal signaling was recently
shown to be regulated by microRNAs in zebrafish and Xenopus
(Choi et al., 2007; Martello et al., 2007). In zebrafish, miR-430 has
been shown to target both a Nodal ligand and Nodal antagonists,
sqt and Lefty1/2, respectively, with its effects strongest on Lefty2
(Choi et al., 2007). miR-430 functions by balancing the expres-
sion of these positive and negative players to achieve optimal
signal levels required for organizer formation and germ layer
specification (Choi et al., 2007). Nodal induces itself as well as
Lefty, and this auto-activatory-inhibitory loop limits signal range,
duration, and level, thus creating borders, patterns, or asymme-
tries (Solnica-Krezel, 2003). The Nodal-Lefty mechanism fits
what is known as the Turing reaction-diffusion model (reviewed
by Solnica-Krezel, 2003). This model explains how noise in an
otherwise uniform diffusion system can become amplified by
the coexpression of a ligand and its antagonist. For this system
to work, the antagonist must be able to diffuse faster than the
ligand, which thus creates short-range activation and long-range
inhibition. Changes in expression levels of either component,
through, for example, the action of miR-430, would influence
signal range, duration, and level. It will be interesting to see if
other microRNAs are involved in Nodal-Lefty regulation at later
stages, such as during L/R specification.
In Xenopus, the Nodal signaling pathway has also been shown
to be modulated by the action of a microRNA, miR-15/16, the
target of which is the type II Nodal receptor ACVR2A (Martello
et al., 2007). While the expression of the miR-15/16 primary tran-
script is ubiquitous, processing of this transcript into mature
functional miR-15 is inhibited by the Wnt/b-catenin pathway.
Since b-catenin accumulates on the dorsal side of the embryo
after fertilization, mature miR-15 is found in a gradient, with the
highest levels ventrally. This feature of miR-15 creates a reverse
expression gradient of ACVR2A, and hence restricts responsive-
ness to Nodal ligands in a spatial manner and controls the size of
the organizer.
In both studies, whether balancing the levels of secreted
agonists and antagonists or spatially restricting responsive
components in the pathway, microRNAs seem to provide
robustness to the signaling and can prevent transcriptional mis-
regulation of signaling components from causing catastrophic
changes during early development.
Modulation of TGF-b Superfamily Signaling by Other
Signal Transduction Pathways
Finally, it is important to consider that TGF-b superfamily
signaling in any given cell does not occur in isolation, but is
subject to modulation by other signaling pathways. The duration
of TGF-b superfamily signaling can be regulated in this way, and
in addition, transcriptional responses to TGF-b superfamily
signals can be influenced due to the integration of multiple signals
at the promoters of target genes.
It is well established that receptor tyrosine kinase (RTK)
signaling can have an antagonistic effect on BMP signaling in
many developmental contexts, such as during neural induction,
limb development, lung morphogenesis, cranial suture fusion,and tooth development (De Robertis and Kuroda, 2004). It now
turns out that the activity of the Smads themselves is directly
influenced by RTK signaling. R-Smads and co-Smads have
a proline-rich linker that connects the MH1 and MH2 domains.
MAPKs activated downstream of RTKs phosphorylate several
serines and threonines in the Smad1 linker, which promotes
binding of the E3 ubiquitin ligase Smurf1. This in turn enhances
degradation of Smad1, which reduces BMP signal transduction,
and curtails responses (Sapkota et al., 2007). The corollary of this
is that any signal that inhibits Smad1 linker phosphorylation
would prolong the duration of BMP signaling. Interestingly, the
MAPK sites in the Smad1 linker act as priming sites for glycogen
synthase kinase 3 (GSK3), which is inhibited by Wnt signaling
(Fuentealba et al., 2007). GSK3 phosphorylation of linker serines
and threonines close to the MAPK sites also destabilizes Smad1,
and thus it has been suggested that Wnt signaling synergizes
with BMP signaling by stabilizing the Smads and increasing
the duration of BMP signaling (Fuentealba et al., 2007).
It is not only the Smads that can integrate signals from other
pathways; Smad-interacting transcription factors can also
perform this function. RTK signaling via Ras has long been
established as a requirement for Nodal/Activin-induced meso-
derm formation in Xenopus embryos, although it was unclear
exactly how it modulated the Nodal signaling pathway. Recent
work has demonstrated that the target of RTK signaling in this
case is the transcription factor p53 (Cordenonsi et al., 2007).
p53 is required for induction of a subset of Nodal target genes
and functions by interacting directly with Smad2 at the
promoters of these genes. RTK signaling via Ras leads to phos-
phorylation of p53 via the kinase CK13/d. This increases the
association of p53 with activated Smad2, and thus promotes
the transcription of mesodermal target genes.
A further informative example of signal integration at the level
of enhancer or promoter elements is the integration of Wnt and
Dpp signals at the Leg Trigger (LT) enhancer of the Distalless
(Dll) gene in Drosophila, which is involved in leg development
(Estella et al., 2008). The LT enhancer contains binding sites
for TCF (which binds an activatory complex of b-catenin,
Legless, and Pygopus in response to Wnt signaling), Mad, and
Brk, and active transcription occurs only when both Wnt and
Dpp signaling is high. This can be explained as follows. When
both signaling pathways are operating, the TCF and Mad sites
bind their respective activatory complexes and the Brk site is
unoccupied; thus, transcription is active. In cells exhibiting low
Dpp signaling, but high Wnt signaling, the binding of Brk to the
enhancer inhibits transcription. Conversely, in cells with high
Dpp signaling, but no Wnt signaling, the binding of activated
Mad complexes is not sufficient for transcriptional activation.
In this way, the spatial domain of Dll transcription is defined by
cells exhibiting simultaneously high Wnt and Dpp signaling.
Perspectives
Our view of TGF-b superfamily signaling pathways has evolved
significantly since a decade ago, when the pathway was
perceived to be a three-step system of receptor activation by
ligands followed by effector molecule activation through phos-
phorylation, resulting in transcriptional activation or repression.
The tremendous effort by scientists around the world using
a combination of developmental, cellular, and molecular systemsDevelopmental Cell 16, March 17, 2009 ª2009 Elsevier Inc. 339
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mechanisms that provide both robustness and diversity to this
signaling system.
It is evident from our discussion that the model organisms and
systems used have different strengths, and thus have been
exploited to address different questions. While playing to the
strengths of specific models is the most efficient way to gain
understanding, integration and consolidation of data between
systems is now essential. For example, transport of BMPs within
their expression domain is established as a mechanism for
gradient formation in the Drosophila blastoderm, and recent
evidence suggests that the same may occur in Xenopus
embryos. However, while Activin dose-dependent responses
are well documented (Green and Smith, 1990), whether Nodal
and Activin utilize similar mechanisms for gradient formation
requires further investigation. Studies in Drosophila have also
revealed an elegant mechanism whereby dose-dependent tran-
scription is controlled by multiple repressive and/or activatory
elements in the promoters of various Dpp target genes. A parallel
mechanism for regulating vertebrate BMP- and Nodal-induced
target gene transcription has not yet been demonstrated,
because the relevant promoter elements have not been studied
to such depth. Finally, it is becoming apparent that in addition
to their complex roles in early development, TGF-b superfamily
signaling pathways are involved in many human diseases as
a result of mutations in components of the pathways or deregula-
tion of signaling. We anticipate that the more we learn about the
functions of these pathways and their mechanisms of action in
embryonic development, the greater will be our ability to under-
stand and treat these diseases.
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